An Innovative Trial Assessing Donor Sex on Recipient Mortality

PHASE4UnknownINTERVENTIONAL
Enrollment

8,850

Participants

Timeline

Start Date

September 4, 2018

Primary Completion Date

January 23, 2021

Study Completion Date

December 1, 2022

Conditions
Red Blood Cell Transfusion
Interventions
OTHER

RBC Transfusion from male donor

Patients requiring an RBC transfusion for the treatment of anemia will receive products from a male donor at initial and any subsequent hospitalizations during the trial period.

OTHER

RBC Transfusion from female donor

Patients requiring an RBC transfusion for the treatment of anemia will receive products from a female donor at initial and any subsequent hospitalizations during the trial period.

Trial Locations (1)

K1H 8L6

Ottawa Hospital - General Campus, Ottawa

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Canadian Blood Services

OTHER

lead

Ottawa Hospital Research Institute

OTHER